ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,136,000 | +48.7% | 308,569 | +211.7% | 2.71% | +358.9% |
| Q1 2016 | $764,000 | -29.2% | 99,000 | -1.0% | 0.59% | -17.1% |
| Q4 2015 | $1,079,000 | +47.2% | 100,000 | -5.8% | 0.71% | +76.0% |
| Q3 2015 | $733,000 | +24.0% | 106,104 | +59.1% | 0.40% | -13.5% |
| Q2 2015 | $591,000 | -10.2% | 66,704 | 0.0% | 0.47% | -15.1% |
| Q1 2015 | $658,000 | +7.3% | 66,704 | +33.4% | 0.55% | -9.2% |
| Q4 2014 | $613,000 | – | 50,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |